Tokyo retreated in the week to March 3, due to weak New York markets and the resurgence of the yen versus the dollar. The Nikkei 225 dropped 6.6%, to finish below the 13,000-mark, while the Topix index fell 6.2%. Investors were encouraged early in the period by US credit rating companies, such as Standard & Poor, affirming the top rating for leading American bond insurers. However, the positive view was eliminated later after the US Federal Reserve Bank's chairman warned about possible bankruptcy of small banks which have real estate investments. Investors worried about the prospect for global credit and financial markets. The pharmaceutical index was off 4.9%, but still outperformed the market.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze